Ning Dai focused on the associations and mechanism underlying expression of IGF2BP2 SNPs and the development of metabolic diseases including T2D, nonalcoholic steatohepatitis, obesity and fatty liver disease. This evidence concerns the gene IGF2BP2 and metabolic dysfunction-associated steatohepatitis.